360 High-Risk Vulnerability Immunization Tool V2.0 vs HarfangLab Vulnerability Assessment: 2026 Comparison

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

HarfangLab Vulnerability Assessment

Mid-market and enterprise teams that can't afford the overhead of continuous manual scanning will see immediate payoff from HarfangLab Vulnerability Assessment; the lightweight agent model delivers daily CVE correlations across your entire endpoint inventory without requiring a separate EDR or EPP layer. The vendor's ability to support air-gapped environments with manual NIST updates and hybrid deployment across cloud and on-premises infrastructure means you're not locked into a single architecture. Skip this if you need vulnerability management tied to threat intelligence or remediation workflow automation; HarfangLab prioritizes detection and prioritization over the downstream response side.